Total planned funding: $326,219,541
Clear active filters
Not Available
Unknown
2005
2006
2007
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zambia | $83,643,877 |
Tanzania | $54,276,353 |
Kenya | $32,556,589 |
Uganda | $27,937,037 |
Mozambique | $20,651,187 |
Democratic Republic of the Congo | $15,581,525 |
South Africa | $15,255,062 |
Ethiopia | $8,300,625 |
Zimbabwe | $8,266,297 |
Lesotho | $7,556,517 |
Malawi | $7,057,213 |
Nigeria | $6,564,653 |
Central Asia Region | $4,893,326 |
Ghana | $4,586,377 |
Burma | $3,975,000 |
Côte d'Ivoire | $3,622,328 |
Botswana | $3,601,699 |
Ukraine | $2,300,000 |
India | $2,250,000 |
Haiti | $2,125,000 |
Caribbean Region | $1,758,861 |
Eswatini | $1,735,123 |
Namibia | $1,437,036 |
Asia Regional Program | $1,400,000 |
Central America Region | $1,290,500 |
Vietnam | $655,150 |
Guyana | $650,000 |
Burundi | $617,288 |
Cambodia | $440,000 |
Dominican Republic | $418,131 |
South Sudan | $412,178 |
Papua New Guinea | $404,609 |
Organizational Types
Unknown | $326,219,541 |
Program Areas
Care | $106,466,961 |
Treatment | $98,615,382 |
Prevention | $62,804,490 |
Governance and Systems | $39,111,460 |
Testing | $19,221,248 |
Budget Codes
HTXS: Treatment: Adult Treatment | $82,671,063 |
HKID: Care: Orphans and Vulnerable Children | $59,146,206 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $27,173,568 |
HBHC: Care: Adult Care and Support | $23,442,158 |
HVCT: Testing: HIV Testing and Counseling | $19,221,248 |
HVTB: Care: TB/HIV | $18,431,988 |
HVSI: Strategic Information | $17,077,942 |
HVOP: Sexual Prevention: Other Sexual Prevention | $16,051,951 |
OHSS: Health Systems Strengthening | $13,362,542 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $11,865,170 |
PDTX: Treatment: Pediatric Treatment | $10,938,974 |
HLAB: Laboratory Infrastructure | $8,670,976 |
PDCS: Care: Pediatric Care and Support | $5,446,609 |
HTXD: Treatment: ARV Drugs | $5,005,345 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,732,388 |
HMIN: Biomedical Prevention: Injection Safety | $2,609,514 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $2,212,021 |
HMBL: Biomedical Prevention: Blood Safety | $159,878 |